16-89917962-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The XM_047435031.1(LOC124903759):​c.1127T>C​(p.Leu376Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.572 in 225,376 control chromosomes in the GnomAD database, including 41,467 homozygotes. In-silico tool predicts a benign outcome for this variant. 5/5 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.59 ( 29907 hom., cov: 34)
Exomes 𝑓: 0.53 ( 11560 hom. )

Consequence

LOC124903759
XM_047435031.1 missense

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0740
Variant links:
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 16-89917962-T-C is Benign according to our data. Variant chr16-89917962-T-C is described in ClinVar as [Benign]. Clinvar id is 321379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.896 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOC124903759XM_047435031.1 linkc.1127T>C p.Leu376Pro missense_variant Exon 3 of 4 XP_047290987.1
LOC124903759XM_047435032.1 linkc.*117T>C 3_prime_UTR_variant Exon 3 of 3 XP_047290988.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MC1RENST00000555427.1 linkc.-494T>C 5_prime_UTR_variant Exon 2 of 4 5 ENSP00000451760.1 G3V4F0
MC1RENST00000639847.1 linkc.-494T>C 5_prime_UTR_variant Exon 2 of 3 5 ENSP00000492011.1 Q01726
ENSG00000267048ENST00000570217.1 linkn.288T>C non_coding_transcript_exon_variant Exon 3 of 3 4

Frequencies

GnomAD3 genomes
AF:
0.594
AC:
90283
AN:
152042
Hom.:
29851
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.865
Gnomad AMI
AF:
0.355
Gnomad AMR
AF:
0.587
Gnomad ASJ
AF:
0.405
Gnomad EAS
AF:
0.917
Gnomad SAS
AF:
0.679
Gnomad FIN
AF:
0.518
Gnomad MID
AF:
0.589
Gnomad NFE
AF:
0.425
Gnomad OTH
AF:
0.548
GnomAD4 exome
AF:
0.526
AC:
38511
AN:
73216
Hom.:
11560
Cov.:
0
AF XY:
0.520
AC XY:
17653
AN XY:
33926
show subpopulations
African (AFR)
AF:
0.866
AC:
2864
AN:
3306
American (AMR)
AF:
0.624
AC:
1377
AN:
2208
Ashkenazi Jewish (ASJ)
AF:
0.404
AC:
1881
AN:
4656
East Asian (EAS)
AF:
0.913
AC:
9727
AN:
10652
South Asian (SAS)
AF:
0.653
AC:
406
AN:
622
European-Finnish (FIN)
AF:
0.547
AC:
35
AN:
64
Middle Eastern (MID)
AF:
0.534
AC:
238
AN:
446
European-Non Finnish (NFE)
AF:
0.418
AC:
18882
AN:
45154
Other (OTH)
AF:
0.508
AC:
3101
AN:
6108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
756
1511
2267
3022
3778
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.594
AC:
90399
AN:
152160
Hom.:
29907
Cov.:
34
AF XY:
0.599
AC XY:
44577
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.865
AC:
35947
AN:
41540
American (AMR)
AF:
0.587
AC:
8983
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.405
AC:
1404
AN:
3470
East Asian (EAS)
AF:
0.917
AC:
4756
AN:
5184
South Asian (SAS)
AF:
0.678
AC:
3268
AN:
4822
European-Finnish (FIN)
AF:
0.518
AC:
5474
AN:
10574
Middle Eastern (MID)
AF:
0.592
AC:
174
AN:
294
European-Non Finnish (NFE)
AF:
0.425
AC:
28906
AN:
67954
Other (OTH)
AF:
0.551
AC:
1164
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1664
3327
4991
6654
8318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
726
1452
2178
2904
3630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.459
Hom.:
29462
Bravo
AF:
0.611
Asia WGS
AF:
0.774
AC:
2694
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Melanoma, cutaneous malignant, susceptibility to, 5 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
5.7
DANN
Benign
0.79
PhyloP100
-0.074
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3212354; hg19: chr16-89984370; COSMIC: COSV73353723; COSMIC: COSV73353723; API